February 7, 2013 / 1:41 PM / 4 years ago

BRIEF-Teva Pharmaceutical reaffirms 2013 outlook

1 Min Read

Feb 7 (Reuters) - Teva Pharmaceutical Industries Chief Financial Officer Eyal Desheh says:

* Reiterates 2013 revenue forecast $19.5-$20.5 bln, adjusted EPS $4.85-$5.15

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below